A citation-based method for searching scientific literature

A Fuchsia Howard, Joan L Bottorff, Lynda G Balneaves, Charmaine Kim-Sing. BMC Womens Health 2010
Times Cited: 21







List of co-cited articles
133 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
28

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
28

Preserving the self: the process of decision making about hereditary breast cancer and ovarian cancer risk reduction.
A Fuchsia Howard, Lynda G Balneaves, Joan L Bottorff, Patricia Rodney. Qual Health Res 2011
40
28

Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent.
D Gareth R Evans, Fiona Lalloo, Linda Ashcroft, Andrew Shenton, Tara Clancy, Andrew D Baildam, Anne Brain, Penelope Hopwood, Anthony Howell. Cancer Epidemiol Biomarkers Prev 2009
102
23

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.
Kelly A Metcalfe, Daphna Birenbaum-Carmeli, Jan Lubinski, Jacek Gronwald, Henry Lynch, Pal Moller, Parviz Ghadirian, William D Foulkes, Jan Klijn, Eitan Friedman,[...]. Int J Cancer 2008
250
23


What I wish I'd known before surgery: BRCA carriers' perspectives after bilateral salipingo-oophorectomy.
Danielle Campfield Bonadies, Anne Moyer, Ellen T Matloff. Fam Cancer 2011
40
23

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
994
23

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
719
19

Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer.
Yoland Antill, John Reynolds, Mary-Anne Young, Judy Kirk, Katherine Tucker, Tarli Bogtstra, Shirley Wong, Tracy Dudding, Juliana Di Iulio, Kelly-Anne Phillips. Eur J Cancer 2006
33
19


Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.
Joanna B Madalinska, Judith Hollenstein, Eveline Bleiker, Marc van Beurden, Heiddis B Valdimarsdottir, Leon F Massuger, Katja N Gaarenstroom, Marian J E Mourits, René H M Verheijen, Eleonora B L van Dorst,[...]. J Clin Oncol 2005
169
19

Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers.
Angela R Bradbury, Comfort N Ibe, James J Dignam, Shelly A Cummings, Marion Verp, Melody A White, Grazia Artioli, Laura Dudlicek, Olufunmilayo I Olopade. Genet Med 2008
67
19



Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction.
Marc D Schwartz, Heiddis B Valdimarsdottir, Tiffani A DeMarco, Beth N Peshkin, William Lawrence, Jessica Rispoli, Karen Brown, Claudine Isaacs, Suzanne O'Neill, Rebecca Shelby,[...]. Health Psychol 2009
75
19


Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.
Tara M Friebel, Susan M Domchek, Susan L Neuhausen, Theresa Wagner, D Gareth Evans, Claudine Isaacs, Judy E Garber, Mary B Daly, Rosalind Eeles, Ellen Matloff,[...]. Clin Breast Cancer 2007
56
14


Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers.
Joanna B Madalinska, Marc van Beurden, Eveline M A Bleiker, Heiddis B Valdimarsdottir, Lottie Lubsen-Brandsma, Leon F Massuger, Marian J E Mourits, Katja N Gaarenstroom, Eleonora B L van Dorst, Hans van der Putten,[...]. J Clin Oncol 2007
55
14


Risk-reduction surgery decisions in high-risk women seen for genetic counseling.
Jessica A Ray, Lois J Loescher, Molly Brewer. J Genet Couns 2005
32
14

Qualitative Evaluation of Medical Information Processing Needs of 60 Women Choosing Ovarian Cancer Surveillance or Prophylactic Oophorectomy.
Sheri A Babb, Elizabeth M Swisher, Hope N Heller, Alison J Whelan, David G Mutch, Thomas J Herzog, Janet S Rader. J Genet Couns 2002
20
15


Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers.
M S van Roosmalen, P F M Stalmeier, L C G Verhoef, J E H M Hoekstra-Weebers, J C Oosterwijk, N Hoogerbrugge, U Moog, W A J van Daal. J Clin Oncol 2004
91
14

Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation.
K A Metcalfe, A Poll, A O'Connor, S Gershman, S Armel, A Finch, R Demsky, B Rosen, S A Narod. Clin Genet 2007
53
14

Women receiving news of a family BRCA1/2 mutation: messages of fear and empowerment.
Cheryl B Crotser, Suzanne S Dickerson. J Nurs Scholarsh 2010
14
21

Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer.
B Meiser, P Butow, M Price, B Bennett, G Berry, K Tucker. J Womens Health (Larchmt) 2003
34
14

Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timing.
A-B Skytte, A-M Gerdes, M K Andersen, L Sunde, K Brøndum-Nielsen, M Waldstrøm, S Kølvraa, D Crüger. Clin Genet 2010
74
14

Decision making and coping in healthcare: the Coping in Deliberation (CODE) framework.
Jana Witt, Glyn Elwyn, Fiona Wood, Kate Brain. Patient Educ Couns 2012
23
14

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.
E J Meijers-Heijboer, L C Verhoog, C T Brekelmans, C Seynaeve, M M Tilanus-Linthorst, A Wagner, L Dukel, P Devilee, A M van den Ouweland, A N van Geel,[...]. Lancet 2000
225
14

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
14

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Noah D Kauff, Jaya M Satagopan, Mark E Robson, Lauren Scheuer, Martee Hensley, Clifford A Hudis, Nathan A Ellis, Jeff Boyd, Patrick I Borgen, Richard R Barakat,[...]. N Engl J Med 2002
876
14

Long-term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance.
Marc D Schwartz, Claudine Isaacs, Kristi D Graves, Elizabeth Poggi, Beth N Peshkin, Christy Gell, Clinton Finch, Scott Kelly, Kathryn L Taylor, Lauren Perley. Cancer 2012
94
14

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
Mary B Daly, Robert Pilarski, Michael Berry, Saundra S Buys, Meagan Farmer, Susan Friedman, Judy E Garber, Noah D Kauff, Seema Khan, Catherine Klein,[...]. J Natl Compr Canc Netw 2017
307
14

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.
Amy P M Finch, Jan Lubinski, Pål Møller, Christian F Singer, Beth Karlan, Leigha Senter, Barry Rosen, Lovise Maehle, Parviz Ghadirian, Cezary Cybulski,[...]. J Clin Oncol 2014
362
14

Decision aids for people facing health treatment or screening decisions.
Dawn Stacey, France Légaré, Krystina Lewis, Michael J Barry, Carol L Bennett, Karen B Eden, Margaret Holmes-Rovner, Hilary Llewellyn-Thomas, Anne Lyddiatt, Richard Thomson,[...]. Cochrane Database Syst Rev 2017
14



Time to decide about risk-reducing mastectomy: a case series of BRCA1/2 gene mutation carriers.
Mary McCullum, Joan L Bottorff, Mary Kelly, Stephanie A Kieffer, Lynda G Balneaves. BMC Womens Health 2007
15
13

Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
Kelly A Metcalfe, Jan Lubinski, Parviz Ghadirian, Henry Lynch, Charmaine Kim-Sing, Eitan Friedman, William D Foulkes, Susan Domchek, Peter Ainsworth, Claudine Isaacs,[...]. J Clin Oncol 2008
122
9

The impact of a false-positive MRI on the choice for mastectomy in BRCA mutation carriers is limited.
N Hoogerbrugge, Y J L Kamm, P Bult, K M Landsbergen, E M H F Bongers, H G Brunner, H J Bonenkamp, J A de Hullu, M J L Ligtenberg, C Boetes. Ann Oncol 2008
21
9

Breast cancer prevention: patient decision making and risk communication in the high risk setting.
Elissa M Ozanne, Eve Wittenberg, Judy E Garber, Jane C Weeks. Breast J 2010
20
10

Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.
Andrea Eisen, Jan Lubinski, Jan Klijn, Pal Moller, Henry T Lynch, Kenneth Offit, Barbara Weber, Tim Rebbeck, Susan L Neuhausen, Parviz Ghadirian,[...]. J Clin Oncol 2005
309
9

Characterization of BRCA1 and BRCA2 mutations in a large United States sample.
Sining Chen, Edwin S Iversen, Tara Friebel, Dianne Finkelstein, Barbara L Weber, Andrea Eisen, Leif E Peterson, Joellen M Schildkraut, Claudine Isaacs, Beth N Peshkin,[...]. J Clin Oncol 2006
226
9

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
872
9

Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study.
K Tiller, B Meiser, P Butow, M Clifton, B Thewes, M Friedlander, K Tucker. Gynecol Oncol 2002
52
9

Whatever happened to qualitative description?
M Sandelowski. Res Nurs Health 2000
9

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
Noah D Kauff, Susan M Domchek, Tara M Friebel, Mark E Robson, Johanna Lee, Judy E Garber, Claudine Isaacs, D Gareth Evans, Henry Lynch, Rosalind A Eeles,[...]. J Clin Oncol 2008
365
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.